Pregnancy and fetal outcomes following maternal exposure to glatiramer acetate in all three trimesters of pregnancy.
Sigal KaplanMikhail ZeygarnikTal SternKerstin HellwigPublished in: European journal of neurology (2023)
In-utero exposure to 20 and 40 mg/mL GA in three trimesters of pregnancy does not appear to be related to adverse pregnancy or infant outcomes.